In an interview with AIDS.gov Director Miguel Gomez, Dr. Carl Dieffenbach discussed how to talk about “a cure” for HIV, and how talk of a cure is different from talk of an “AIDS-free generation.” Dr. Dieffenbach is Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases (NIAID). According to…
USG at AIDS 2012: Video with Dr. Anthony Fauci
Dr. Howard Koh, Assistant Secretary for Health at HHS, sat down with Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at NIH to discuss his speech at the opening plenary of AIDS 2012 and his 31 years as a physician and leader in HIV/AIDS scientific research. Having participated in International…
Turning the Tide Together: Looking To the XIX International AIDS Conference in Washington, D.C.
June 14, 2012 • 0 comments • By Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases at the National Institutes of Health, and Gregory K. Folkers, M.S., M.P.H., Chief of Staff to Dr. Fauci
Next month, the International AIDS Conference returns to Washington, D.C., where it was last held in 1987. One of us (ASF) had the privilege of speaking at the 1987 conference, and will do so again this year. At the Washington conference 25 years ago, the mood was somber. The HIV/AIDS pandemic was expanding rapidly. Although…
NIAID Advances Efforts to Restructure Clinical Trials Networks with Funding Announcements
February 3, 2012 • 0 comments • By Miguel Gomez, Director, AIDS.gov, and Senior Communications Advisor, Office of HIV/AIDS Policy, U.S. Department of Health and Human Services
Over the past year and a half, many of you followed the AIDS.gov blog post series Future Directions for NIAID HIV Research by Dr. Carl Dieffenbach, Director of the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID) at NIH. Last week, NIAID advanced those efforts by issuing several requests for applications (RFAs)…
Community Engagement in NIAID’s HIV/AIDS Clinical Trials Networks
September 29, 2011 • 2 comments • By Carl Dieffenbach, Ph.D., Director of the Division of AIDS, NIAID
Since early in the HIV/AIDS epidemic, the National Institute of Allergy and Infectious Diseases (NIAID) has involved community representatives and advocates in the research process. The nature and scope of the community’s involvement have grown over the years, but the rationale behind these efforts remains the same: the people who might benefit from the research…
The Future of the NIAID Clinical Trial Units
June 28, 2011 • 2 comments • By Manizhe Payton, Director, Office of Clinical Oversight, Division of AIDS, National Institute of Allergy and Infectious Diseases
As the National Institute of Allergy and Infectious Diseases (NIAID) moves forward to restructure its HIV/AIDS Clinical Trials Networks and include a new network focused on infectious diseases other than AIDS, the Clinical Trial Units (CTUs) will continue to play a critical role in establishing, developing, and implementing the networks’ scientific research agendas. Additionally, we…
What You Missed: Open for Questions 30 Years of AIDS
Yesterday, Surgeon General Dr. Regina Benjamin, Director of the White House Office of National AIDS Policy Jeffrey Crowley and Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, NIH, Dr. Carl Dieffenbach came to the White House for a special live chat on 30th anniversary of the AIDS epidemic….
Upcoming Event: NIH’s Dr. Fauci’s Talk “Thirty Years of HIV/AIDS: A Personal Journey”
May 23, 2011 • 0 comments • By Miguel Gomez, Director, AIDS.gov, and Senior Communications Advisor, Office of HIV/AIDS Policy, U.S. Department of Health and Human Services
June 5, 2011 will mark 30 years since the first cases of AIDS were reported in the U.S. On Tuesday, May 31, at 2pm ET, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), will be giving a talk, “Thirty Years of HIV/AIDS:…